What does ID Farma do?

ID Farma is filed with the CBE under the catch-all “Overige financiële dienstverlening”, a code that says little about what the company actually does. Private Limited, started on 21 January 2016, 1 establishment.

What is the address of ID Farma?

The registered office of ID Farma is located at Liersebaan 1, 2240 Zandhoven.

Is ID Farma still active?

Yes. According to the CBE (16 September 2026) ID Farma is active, legal situation “Normale toestand”, started on 21 January 2016.

Is ID Farma registered on Peppol?

Yes, ID Farma is registered on the Peppol network with ID 0208:0646871719.

What is the enterprise number of ID Farma?

The enterprise number of ID Farma is BE0646871719.

When was ID Farma founded?

ID Farma was founded on 21 January 2016.

Who are the directors of ID Farma?

According to the 2025 annual accounts, the directors of ID Farma are: Isabelle Denys.

Is ID Farma a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 21 January 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ID Farma make in 2025?

ID Farma posted a profit after taxes of € 86,500 in financial year 2025.

What is the revenue of ID Farma?

As a small company, ID Farma is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 153,078.

Does ID Farma have a website?

Yes, ID Farma has a website at apotheekdenyszandhoven.be.

ID Farma (Private Limited) - Zandhoven - BE0646871719

Dossier ID Farma, printed on 16 September 2026 from databakkes.be/en/0646871719/id-farma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 21 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ID Farma from Zandhoven, company number BE0646871719, closed financial year 2025 with a result of € 86,500 after tax. For that financial year ID Farma recorded a gross margin of € 153,078 and equity of € 769,822. Compared with financial year 2024, the result moved from € 84,712 to € 86,500. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.

What it is worth Growing

€ 769,822

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 86,500

▲ 2% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,562

▼ 13% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 751,222.

People and assets in 2025

Vehicles and equipment

€ 3,236

▼ 79% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 718,933

▼ 1% vs 2024

€ 99,509 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 301

▲ 33% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,675

▼ 11% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 115,036 Gross margin 2022: € 115,036 First fiscal year in the series	€ 162,071 Gross margin 2023: € 162,071 ▲ 41% vs 2022 (€ 115,036) Favourable step	€ 157,519 Gross margin 2024: € 157,519 ▼ 3% vs 2023 (€ 162,071) Unfavourable step	€ 153,078 Gross margin 2025: € 153,078 ▼ 3% vs 2024 (€ 157,519) Unfavourable step	▼ 3%
Profit after taxes	€ 60,369 Profit after taxes 2022: € 60,369 First fiscal year in the series	€ 90,574 Profit after taxes 2023: € 90,574 ▲ 50% vs 2022 (€ 60,369) Favourable step	€ 84,712 Profit after taxes 2024: € 84,712 ▼ 6% vs 2023 (€ 90,574) Unfavourable step	€ 86,500 Profit after taxes 2025: € 86,500 ▲ 2% vs 2024 (€ 84,712) Favourable step	▲ 2%
Equity	€ 508,036 Equity 2022: € 508,036 First fiscal year in the series	€ 598,610 Equity 2023: € 598,610 ▲ 18% vs 2022 (€ 508,036) Favourable step	€ 683,322 Equity 2024: € 683,322 ▲ 14% vs 2023 (€ 598,610) Favourable step	€ 769,822 Equity 2025: € 769,822 ▲ 13% vs 2024 (€ 683,322) Favourable step	▲ 13%
Total debts	€ 1,074,359 Total debts 2022: € 1,074,359 First fiscal year in the series	€ 976,184 Total debts 2023: € 976,184 ▼ 9% vs 2022 (€ 1,074,359) Favourable step	€ 898,812 Total debts 2024: € 898,812 ▼ 8% vs 2023 (€ 976,184) Favourable step	€ 795,099 Total debts 2025: € 795,099 ▼ 12% vs 2024 (€ 898,812) Favourable step	▼ 12%
Cash	€ 16,632 Cash 2022: € 16,632 First fiscal year in the series	€ 17,263 Cash 2023: € 17,263 ▲ 4% vs 2022 (€ 16,632) Favourable step	€ 36,423 Cash 2024: € 36,423 ▲ 111% vs 2023 (€ 17,263) Favourable step	€ 31,562 Cash 2025: € 31,562 ▼ 13% vs 2024 (€ 36,423) Unfavourable step	▼ 13%
Retained profit	€ 489,436 Retained profit 2022: € 489,436 First fiscal year in the series	€ 580,010 Retained profit 2023: € 580,010 ▲ 19% vs 2022 (€ 489,436) Favourable step	€ 664,722 Retained profit 2024: € 664,722 ▲ 15% vs 2023 (€ 580,010) Favourable step	€ 751,222 Retained profit 2025: € 751,222 ▲ 13% vs 2024 (€ 664,722) Favourable step	▲ 13%
Bank debt	€ 950,987 Bank debt 2022: € 950,987 First fiscal year in the series	€ 838,648 Bank debt 2023: € 838,648 ▼ 12% vs 2022 (€ 950,987) Favourable step	€ 724,876 Bank debt 2024: € 724,876 ▼ 14% vs 2023 (€ 838,648) Favourable step	€ 718,933 Bank debt 2025: € 718,933 ▼ 1% vs 2024 (€ 724,876) Favourable step	▼ 1%
Balance sheet total	€ 1,582,394 Balance sheet total 2022: € 1,582,394 First fiscal year in the series	€ 1,574,794 Balance sheet total 2023: € 1,574,794 Unchanged (€ 1,582,394) Unchanged	€ 1,582,134 Balance sheet total 2024: € 1,582,134 Unchanged (€ 1,574,794) Unchanged	€ 1,564,920 Balance sheet total 2025: € 1,564,920 ▼ 1% vs 2024 (€ 1,582,134) Unchanged	▼ 1%

Key figures of ID Farma, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ID Farma?

What happened at ID Farma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 26, 2026 New annual accounts for financial year 2025: profit of € 86,500 (▲ 2% vs 2024). Source: NBB ↗
Jan 21, 2016 New establishment in Zandhoven. KBO
2016 Isabelle Denys became a director. NBB
Jan 21, 2016 Start of the company according to the CBE. KBO

In short

From € 60,369 profit in 2022 to € 86,500 profit in 2025.

Paid € 113,898 in corporate taxes since 2022.

Best year ever: 2023, with € 90,574 profit.

Original PDFs at the National Bank ↗

A new publication or filing at ID Farma? We notify you, reason included.

Follow ID Farma

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Isabelle Denys

ID Farma

Fold Invest BV 50%

Apotheek Denys Zandhoven BVBA 50%

Behind ID Farma is Isabelle Denys. It owns 50% of Fold Invest BV and 50% of Apotheek Denys Zandhoven BVBA itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Isabelle Denys

Director

since 2016

Establishments

Establishment units

Physical locations of this company

Registered office

Liersebaan 1

2240 Zandhoven

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

APOTHEEK DENYS ZANDHOVEN same network

€ 397,159 gross margin · 2025

Hair By Marcia

CD Farma

€ 152,975 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekdenyszandhoven.be

Technologies

AMPAlpine.jsCookie ConsentGoogle FontsNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Website info

HTTPS Ja

Indexable pages 52,838

Languages NL

Features

Webshop Newsletter

Details

Company number: 0646.871.719
VAT number: BE 0646.871.719
Registered office: Liersebaan 1, 2240 Zandhoven
Names & denominations: ID Farma
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 21 January 2016
Peppol: Active · Active since 1 Jan 2001
Contact: apotheekdenyszandhoven.be
Activities · NACE: Overige financiële dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗